Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Kineta and Pfizer collaborate to develop RIG-I agonist immunotherapies for cancer

Dec. 18, 2018

Staten Biotechnology, Novo Nordisk enter collaboration and option agreement in hypertriglyceridemia

Dec. 18, 2018

C4X Discovery and Horizon Discovery establish target discovery partnership

Dec. 17, 2018

Axovant licenses gene therapies for GM1 and GM2 gangliosidosis from University of Massachusetts

Dec. 17, 2018

Virginia Tech collaborates with NIH to study ML-351 for chronic pain

Dec. 14, 2018

GARDP to screen libraries from Eisai and Takeda for new antibiotics

Dec. 14, 2018

Lilly and AC Immune enter agreement to research and develop tau aggregation inhibitors

Dec. 14, 2018

Entera Bio and Amgen collaborate on oral large molecule programs

Dec. 13, 2018

Merck & Co. and Instituto Butantan to develop dengue vaccines

Dec. 13, 2018

Almirall and X-Chem to develop oral dermatological treatments

Dec. 13, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...